Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended for multimodal postoperative pain management. We evaluated opioid-sparing effects and rehabilitative results after ...

The FDA ( Food and Drug Administration ) has approved Celebrex ( Celecoxib ) for a new use: the relief of the signs and symptoms of juvenile rheumatoid arthritis in patients two years of age and older ...

Celebrex (celecoxib) and ibuprofen are both classified as nonsteroidal anti-inflammatory drugs (NSAIDs). Both are commonly ...

In fact, the totality of evidence supports the use of Celebrex to manage pain and inflammation in people with osteoarthritis or rheumatoid arthritis who also have or are at high risk for ...

Though Celebrex reduces the possibility of growth of colon polyps to half, it doubles the risk of serious heart troubles. Though Celebrex reduces the possibility of growth of colon polyps to half ...

However, some of the medications commonly used to treat RA – including hydroxychloroquine (Plaquenil), methotrexate and nonsteroidal anti-inflammatory drugs (NSAIDs) such as naproxen (Naprosyn) or ...

However, placebo usage may present ethical concerns in the postoperative care of TKA surgery; we therefore adopted an active-control trial design that compared celebrex treatment to the standard ...

200mg and 400 mg are AB rated generic version of Pfizer’s Celebrex Capsules of the same strength. The medicines are used for treating Osteoarthritis, Rheumatoid Artritis and Juvenile Rheymatoid ...